Advanced Modalities
Analytical & Bioanalytical Services
Company Overview
About
Samabriva is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:United Kingdom
Founded:1991
Employees:750
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
BSL-2 (Biosafety Level 2)
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
Europe
Regulatory Approvals
Drug Approval N4GHM7
Health Canada · #APR-07TQIU20 · 2020-02-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-6LFWO11O
Issued: 2020-12-16
Expires: 2025-08-06
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-MPHIHJNH
Issued: 2020-09-09
Expires: 2025-09-09
Loading CDMO intelligence...
Key facts about Samabriva
- Samabriva is headquartered in the United Kingdom.
- Samabriva was founded in 1991.
- Samabriva has 750 employees.
- Samabriva's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Samabriva
Directory pages this company appears in, each with the full list of matching manufacturers.